Synovus Financial (NYSE:SNV) disappointed investors with a 423.7 million dollar net loss for the third quarter, or a dollar 27 per share. Results were pressured by just over 606 million dollars of total credit costs, including a provision expense of 496.5 million and foreclosed real estate costs of 101.4 million. A bright spot in the report was core deposit growth of 3.4% year over year. Synovus shares tumbled nearly 18% in Friday trading.
Ramtron International (RMTR), maker of semiconductor products, earned a penny per share in the third quarter, down from a nickel in the same quarter last year. Revenue plunged 33% year over year, but sales of serial memory products grew significantly quarter over quarter. On Friday shares of Ramtron were off more than 17 and a half percent.
And shares of Dynavax Technologies (NASDAQ:DVAX) were down more than 14% after reporting third quarter results. Revenue plunged 67% year over year, driven by lower collaboration revenue after the termination of the collaboration with Merck (NYSE:MRK) for Dynavax's lead product HEPLISAV. That led to a loss of 24 cents per share, compared to a 14 cent loss in the same quarter last year.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.